CardioLync

Platform for Interpreting, Reporting, and Engaging with Patients

Health Tech & Life Sciences
Non Active, Nov 2022 ceased to operate

Company Overview

Snapshot

Founded in January 2016 by Jeremy Kagan and Jacob Levy, MD FACC, CardioLync operated with 1–10 employees. The company was selected to present at the 2017 New England Venture Summit, highlighting its early recognition in the industry.

Business overview

CardioLync developed a platform designed to streamline the interpretation and reporting of cardiovascular studies, alongside patient management of their cardiac history. The company's technology provides an easy-to-use interface that securely moves clinical data, enabling clinicians to interpret diagnostic studies remotely and patients to access their imaging history from anywhere. CardioLync operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare, Clinical Workflow, and Patient Engagement, serving healthcare providers and patients in the United States and Europe.

Strategic signal

In August 2021, CardioLync joined NVIDIA Inception, a program designed to nurture cutting-edge startups. This collaboration signaled a strategic move to leverage advanced AI and GPU technologies, indicating the company's commitment to enhancing its platform's capabilities and potentially accelerating its technological development within the digital health space.

Company Intelligence Q&A

What is CardioLync's primary offering?
CardioLync provides a platform for interpreting cardiovascular studies, reporting, and patient management of their cardiac history, facilitating seamless and secure movement of clinical data.
When was CardioLync founded and by whom?
CardioLync was founded in January 2016 by Jeremy Kagan and Jacob Levy, MD FACC.
What significant recognition did CardioLync receive in 2017?
In December 2017, CardioLync was selected to present at the New England Venture Summit.
What strategic partnership did CardioLync enter in 2021?
In August 2021, CardioLync joined NVIDIA Inception, a program for startups leveraging AI and GPU technologies.
What is the current operational status of CardioLync?
CardioLync ceased to operate in November 2022 and is currently listed as Non-Active.

External links